Order Article Reprints

Trebucq LL, Cardama GA, Lorenzano Menna P, Golombek DA, Chiesa JJ, Marpegan L. Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma. Pharmaceutics. 2021; 13(7):1091. https://doi.org/10.3390/pharmaceutics13071091

Trebucq, Laura Lucía, Georgina Alexandra Cardama, Pablo Lorenzano Menna, Diego Andrés Golombek, Juan José Chiesa, and Luciano Marpegan. 2021. "Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma" Pharmaceutics 13, no. 7: 1091. https://doi.org/10.3390/pharmaceutics13071091

Trebucq, L. L., Cardama, G. A., Lorenzano Menna, P., Golombek, D. A., Chiesa, J. J., & Marpegan, L. (2021). Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma. Pharmaceutics, 13(7), 1091. https://doi.org/10.3390/pharmaceutics13071091